Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00815204 · ClinicalTrials.gov registry record
Measurement of Pituitary Volume and Hormonal Changes in Patients With Post-traumatic Stress Disorder
A clinical trial of Posttraumatic Stress Disorder, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 39
- Enrollment target
- 1
- Study location
NCT00815204 is a study of Posttraumatic Stress Disorder that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 39 participants, below the 112-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00815204, a study of Posttraumatic Stress Disorder, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
Approximately, post-traumatic stress disorder (PTSD) occurs in 8% of the adult population over time. Exposure to traumatic events increases the risk of poor physical health and often leads to disability. The biology of PTSD is continually being explored in order to help find better treatments for this debilitating disorder. In our study, we propose to further our understanding of PTSD. Prior research has found that patients with PTSD have changes in the stress hormone pathway. In this pathway, there is release of certain hormones from the pituitary gland in the brain that feed into the blood stream and tell the adrenal gland to produce stress hormones. The pituitary is a gland located at the base of the brain which controls the hormones in the body, including the stress hormones. Research in other psychiatric disorders has found changes in the pituitary volume along with changes in the hormones. This has not been investigated yet in PTSD. Therefore, we propose in our study to measure pituitary volume in people with PTSD and look at the changes in the stress hormone pathway. Moreover, we will investigate whether other hormones are affected by PTSD. In this way, we can further our understanding of the the biology of PTSD and help develop new therapies which can intervene through the hormonal system.
Conditions Studied
Interventions
- PROCEDURE MRI of the pituitary
- PROCEDURE DEX/CRH test
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2008-05 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00815204
The ClinicalTrials.gov registry entry for NCT00815204 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 112-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (65% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which MRI of the pituitary is the first listed.
NCT00815204 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00815204 about?
NCT00815204 is a clinical study titled "Measurement of Pituitary Volume and Hormonal Changes in Patients With Post-traumatic Stress Disorder". Approximately, post-traumatic stress disorder (PTSD) occurs in 8% of the adult population over time. Exposure to traumatic events increases the risk of poor physical health and often leads to disability. The biology of PTSD is continually being explored in order to help find better treatments for th...
What is the current status of trial NCT00815204?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2008-05. Estimated completion is 2014-07.
What conditions does trial NCT00815204 study?
This clinical trial studies the following conditions: Posttraumatic Stress Disorder.
What interventions are being tested in trial NCT00815204?
The interventions under investigation include: MRI of the pituitary (PROCEDURE), DEX/CRH test (PROCEDURE).
Who is sponsoring clinical trial NCT00815204?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00815204 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Posttraumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Enhancing Week-long Psychological Treatment for PTSD With Ketamine
RECRUITING · Phase 2
-
Positive Processes and Transition to Health (PATH)
RECRUITING · NA
-
Impact of Cognitive Behavioral Therapy on PTSD-CVD Link
RECRUITING · NA
-
A Mechanistic Trial of the Neurobiology of Extinction Learning and Intraparietal Sulcus Stimulation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.